A translational roadmap for BBB-penetrant nanomedicines (IMAGE)

Science China Press

A translational roadmap for BBB-penetrant nanomedicines

Caption

The roadmap highlights major barriers to translating BBB-penetrant nanomedicines for glioblastoma, including heterogeneous BBB and blood-tumor barrier access, limitations of current models, formulation quality control and the need for integrated clinical readouts.

Credit

©Science Bulletin. Created with BioRender.com.

Usage Restrictions

use with credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.